These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2685535)

  • 1. [Katacalcin levels in healthy children and children with spasmophilia].
    Saggese G; Bertelloni S; Baroncelli GI; Buggiani B; Gualtieri M; Paci A
    Minerva Pediatr; 1989 Sep; 41(9):459-66. PubMed ID: 2685535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
    Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
    Takami H
    Exp Clin Endocrinol; 1994; 102(5):370-3. PubMed ID: 7867699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
    Raue F; Blind E; Grauer A
    Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
    Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosecretion of calcitonin gene products: studies with a C18 cartridge extraction method for human plasma PDN-21 (katacalcin).
    Hurley DL; Katz HH; Tiegs RD; Calvo MS; Barta JR; Heath H
    J Clin Endocrinol Metab; 1988 Mar; 66(3):640-4. PubMed ID: 3350911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.
    Verga U; Morpurgo PS; Vaghi I; Radetti G; Beck-Peccoz P
    Horm Res; 2006; 66(1):17-20. PubMed ID: 16636574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
    Navarro MA; Formiga F; Blanco A; Bonnin MR; Nolla JM; Moga I
    J Rheumatol; 1995 Dec; 22(12):2238-40. PubMed ID: 8835555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin secretion in congenital nongoitrous cretinism.
    Carey DE; Jones KL; Parthemore JG; Deftos LJ
    J Clin Invest; 1980 Apr; 65(4):892-5. PubMed ID: 7358848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
    Blind E; Raue F; Klaiber T; Zink A; Schroth J; Buhr H; Ziegler R
    J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of rat brain regional distribution of calcitonin, katacalcin and calcitonin gene-related peptide before and after antipsychotic treatment.
    Angelucci F; Gruber SH; Mathé AA
    Neuropeptides; 2001; 35(5-6):285-91. PubMed ID: 12030813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid calcitonin response to experimental hypercalcemia in healthy horses.
    Rourke KM; Kohn CW; Levine AL; Rosol TJ; Toribio RE
    Domest Anim Endocrinol; 2009 May; 36(4):197-201. PubMed ID: 19135828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin levels in normal subjects according to age and sex.
    Loré F; Galli M; Franci B; Martorelli MT
    Biomed Pharmacother; 1984; 38(5):261-3. PubMed ID: 6525423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDN-21: possible tumor marker for medullary thyroid carcinoma.
    Takami H; Shikata J; Horie H; Sekine K; Ito K
    J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological aspects of calcium metabolism in spasmophilia.
    Nuti R; Turchetti V; Martini G; Righi G; Galli M; Loré F
    Biomed Pharmacother; 1987; 41(2):96-100. PubMed ID: 3607262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin- and katacalcin-like immunoreactivity in human seminal plasma.
    Maier U; Woloszczuk W; Schuh H; Zechner O
    Exp Clin Endocrinol; 1986 Nov; 88(1):89-94. PubMed ID: 3817006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
    Emmertsen K; Marqversen J; Jensen FT; Hansen HH
    Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced parathyroid hormone response to peroral phosphate in osteoporotic patients.
    Ittner J; Dambacher MA; Muff R; Rüegsegger P; Trechsel U; Fischer JA
    Miner Electrolyte Metab; 1986; 12(3):199-203. PubMed ID: 3014300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antipeptide antibodies as tools to dissect closely related gene products. A model using peptides encoded by the calcitonin gene.
    Ghillani P; Motté P; Bohuon C; Bellet D
    J Immunol; 1988 Nov; 141(9):3156-63. PubMed ID: 3171184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Katacalcin: a new plasma calcium-lowering hormone.
    Hillyard CJ; Myers C; Abeyasekera G; Stevvensvenson JC; Craig RK; MacIntyre I
    Lancet; 1983 Apr; 1(8329):846-8. PubMed ID: 6132180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.